Welcome to our dedicated page for Lifevantage news (Ticker: LFVN), a resource for investors and traders seeking the latest updates and insights on Lifevantage stock.
LifeVantage Corporation reports developments for a health and wellness company built around nutrigenomics, dietary supplements, skin and hair care products, nootropic energy drink mixes, and pet supplements. Its product line includes Protandim, TrueScience Liquid Collagen, MindBody GLP-1 System, LoveBiome P84, AXIO, TrueScience skin and hair care products, and Petandim, sold through independent Consultants to customers.
Company news commonly covers quarterly results, regional sales trends, product innovation, patents tied to cellular-signaling supplement compositions, consultant events and training, international market expansion, executive leadership changes, share repurchases, and cash dividends. Updates also describe capital allocation and the company’s direct-selling business model.
LifeVantage (Nasdaq: LFVN) will release its fourth quarter and full fiscal year 2026 financial results, for the period ended June 30, 2026, after the market close on Thursday, August 27, 2026.
The company will host an investor conference call at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) the same day, with U.S. access at (877) 704-4453 and international access at (201) 389-0920. A telephone replay will be available until September 17, 2026 using confirmation code 13761673, and a live webcast plus a 30-day archive will be accessible via the LifeVantage investor relations website or directly through the provided webcast link.
LifeVantage (Nasdaq: LFVN) announced that its Board granted inducement equity awards to new President and CEO Terrence Moorehead under the 2026 New Employee Long-Term Incentive Plan, in accordance with Nasdaq Listing Rule 5635(c)(4). The awards were granted on August 6, 2026.
The package includes 308,642 RSUs, vesting in three equal annual installments starting one year from grant, and 540,123 performance-based RSUs that may vest over three years based on revenue and Adjusted EBITDA margin targets, in each case subject to Mr. Moorehead’s continued service.
LifeVantage (Nasdaq: LFVN) announced that Terrence Moorehead has officially joined the company as President and Chief Executive Officer and as a member of the Board of Directors, effective August 5, 2026. His appointment was originally announced on April 16, 2026.
According to LifeVantage, Moorehead brings over 25 years of global leadership experience in consumer wellness, brand transformation, and digital modernization, including serving as President and CEO of Nature’s Sunshine Products, where he led a multi-year transformation that modernized the brand, enhanced digital and commercial capabilities, and supported sustained growth in revenue and profitability. LifeVantage’s Board highlights his strategic vision, disciplined execution, and experience with science-backed wellness brands as key strengths for advancing the company’s strategy and creating long-term value.
LifeVantage (Nasdaq:LFVN) announced an 11% increase in its quarterly cash dividend to $0.050 per share. The dividend will be paid on June 15, 2026 to shareholders of record at the close of business on June 1, 2026.
This action reflects a board-approved cash distribution scheduled for mid-June 2026.
LifeVantage (Nasdaq: LFVN) reported third quarter fiscal 2026 results for the period ended March 31, 2026. Revenue was $43.7 million, down 25.2% year-over-year; net income per diluted share was $0.11. Adjusted EBITDA was $3.2 million. Cash and cash equivalents were $12.5 million and no debt was outstanding. The company declared a $0.05 quarterly cash dividend payable June 15, 2026. LifeVantage said it repurchased ~250,000 shares for ~$1.6 million YTD and expects FY2026 results near the lower end of prior guidance ranges.
LifeVantage (Nasdaq:LFVN) will release third quarter fiscal 2026 results for the period ended March 31, 2026, after market close on Wednesday, May 6, 2026. A conference call for investors is scheduled for 2:30 p.m. MT / 4:30 p.m. ET that day.
Telephone dial-in numbers, replay details with confirmation code, and a simultaneous live webcast (archived ~30 days) are provided for investor access.
LifeVantage (Nasdaq: LFVN) received U.S. Patent No. 12,589,067 B2 (issued March 31, 2026) for its Healthy Glow Essentials Stack, covering compositions and methods pairing Protandim Nrf2 Synergizer and TrueScience Liquid Collagen.
The patent cites synergistic activation of cellular signaling genes and fibroblast study results supporting skin benefits and broader cellular-health effects, reflecting over three years of the company’s R&D work.
LifeVantage (Nasdaq: LFVN) concluded its three-day Momentum Academy in Las Vegas on April 20, 2026, focused on leadership, product innovation and Consultant empowerment.
Highlights: introduction of two limited-time AXIO flavors, a U.S. patent granted for the Healthy Glow Essentials Stack, renewed Clean Commitment packaging efforts, and a planned CEO transition with Steve Fife retiring April 30 and Terrence Moorehead joining August 5 (with Michael Beindorff as interim CEO).
LifeVantage (Nasdaq: LFVN) announced Terrence Moorehead will become President and CEO, and join the board, effective August 5, 2026. Mr. Moorehead brings 25+ years of direct‑selling and consumer products experience, including leading Nature’s Sunshine where revenue rose 45% and EBITDA 190%.
Steve Fife will retire effective April 30, 2026; an interim team will lead the company until Mr. Moorehead assumes the role.
LifeVantage (Nasdaq: LFVN) will participate in the Water Tower Research Insights Conference on Wednesday, April 15, 2026. Senior management — CEO Steve Fife, CSO Kristen Cunningham, and VP R&D Lisa Barnes — will present. The webcast begins at approximately 12:30 p.m. ET and is open access.
According to the company, investors can register via the investor relations website to access the live webcast and related materials.